Today: 12 May 2026
Gold and Silver Price Today: Gold Falls to $4,451, Silver Slides as Oil Spike Revives Rate-Hike Fears
26 March 2026
2 mins read

Gold and Silver Price Today: Gold Falls to $4,451, Silver Slides as Oil Spike Revives Rate-Hike Fears

LONDON, March 26, 2026, 09:22 GMT

  • Spot gold slipped 1.2% to $4,451.47 an ounce as of 0811 GMT. Spot silver dropped 2.7%, trading at $69.36.
  • Brent crude pushed up to $104.30 a barrel, with inflation worries resurfacing as hopes for a ceasefire slipped away.

Gold slid over 1% Thursday, with silver posting an even steeper drop, after oil climbed back above $100 a barrel. Confusion around a U.S. plan to resolve the Iran war fueled inflation and interest-rate worries, pulling traders away from precious metals. The move kept gold and silver weighed down, despite persistent geopolitical tensions.

Gold typically serves as a crisis hedge, but this time, the market’s not responding in the usual way. Rising crude prices are stoking bets that central banks hold rates higher—or even hike—which makes the zero-yield metal less appealing.

Spot gold slipped 1.2% to $4,451.47 an ounce as of 0811 GMT. U.S. gold futures for April delivery lost 2.3%, settling at $4,448. Spot silver dropped 2.7% to $69.36. Platinum was down 2.3%, and palladium declined 2.5%. The slide hit all major precious metals.

Odds of a U.S. rate hike by December have climbed to 37%, CME FedWatch data shows, while traders are barely pricing in any chance of a cut. That’s a sharp shift from earlier expectations: before the conflict, at least two cuts were widely anticipated this year.

Trade nerves were on display Wednesday. Gold initially bounced back, up 1.8% to $4,552.94, helped by a pullback in oil and some cooling in rate hike fears. That uptick faded quickly.

Peter Grant, vice president and senior metals strategist at Zaner Metals, pointed to optimism around easing Iran-related tensions as a factor behind the rebound. That sentiment faded by Thursday, though, as Brent slipped to $104.30 a barrel at 0638 GMT.

Charu Chanana, Saxo’s chief investment strategist, put it bluntly: “one peace rumour does not undo the inflation and rates damage already in the system.” Ilya Spivak, who runs global macro at Tastylive, broke down the reaction: war pushes up inflation, central banks step in, and tighter rates hit gold. Reuters

It’s not just about the Fed. On Wednesday, ECB President Christine Lagarde floated the idea of a “measured” rate hike if the war ends up pushing euro zone inflation past target. That’s another signal bullion’s facing bigger forces: a potential global shift in rate expectations. Reuters

Positioning is playing its part as well. Helen Jewell, international chief investment officer for fundamental equities at BlackRock, noted in a Reuters piece that gold is now “a very crowded trade.” In her view, with so much money flowing in, plenty of investors are on the same side, leaving the metal vulnerable if fund managers start de-risking and moving to cash. Reuters

But technicals might take a back seat here. For Kyle Rodda, senior financial market analyst at Capital.com, the next 24 to 48 hours are set to hinge on news out of negotiation rooms. Major price action probably waits until it’s clearer if Washington is going to ramp up its military response.

If diplomacy takes a softer line and oil prices drop, gold might find some footing. Grant thinks gold has a shot at $5,000—if inflation fears cool off enough to revive talk of a U.S. rate cut. On the flip side, a sharper energy jolt could tip things, putting both gold and silver at risk for renewed selling pressure.

Despite the recent tumble, conditions remain extraordinary. Gold surged 64% last year and set a record at $5,594.82 on Jan. 29. Now, though, it’s staring down a 14% monthly decline—its worst since October 2008.

Stock Market Today

  • QuantumScape Shares Rise 9.35% After Q1 Earnings Beat Expectations
    May 12, 2026, 5:51 PM EDT. QuantumScape Corporation (NASDAQ: QS) shares jumped 9.35% following its Q1 2026 earnings report, which showed a smaller-than-expected loss of $0.16 per share versus Wall Street's forecast of $0.18. Despite continuing losses of $100.8 million driven by heavy R&D spending, QS's strong cash position of $904.7 million and a working capital cushion of $872.1 million reassure investors. The stock's advance from mid-$6s in late April to around $8.26 on May 11 reflects growing optimism about the firm's solid-state lithium-metal battery technology. Market participants remain focused on progress toward commercialization, with robust trading momentum indicating confidence in QS's potential for electric vehicle applications.

Latest article

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

12 May 2026
British American Tobacco shares jumped 5.82% in London to £46.34 after the FDA signaled a softer enforcement stance on some e-cigarette and nicotine pouch products. A U.S. judge also dismissed BAT’s North Korea sanctions case following a $630 million settlement. The FTSE 100 slipped 0.04%. BAT’s U.S.-listed ADR closed up 5.3% at $63.64.
Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

12 May 2026
Camtek shares fell 15.8% to $174.63 despite beating Q1 revenue and adjusted EPS estimates by small margins. Q1 revenue rose 2.5% year over year, but non-GAAP EPS dropped to $0.70 from $0.79 and operating margin narrowed to 25.5%. Management guided Q2 revenue to $129–$131 million and expects second-half revenue to rise over 25%. Broader market pressure followed a hot April CPI and rising Treasury yields.
Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health Stock Extends Post-Earnings Repricing as Margins Outweigh ACA Risk

12 May 2026
Oscar Health shares rose 7.9% to $23.73 late Tuesday, with volume near 13 million, after posting strong Q1 profit and lower claims costs despite missing revenue estimates. The company’s medical loss ratio fell to 70.5% from 75.4% a year earlier. Membership climbed to 3.17 million. ACA enrollment churn and policy risk remain concerns.
Microsoft Stock Price Today: Why MSFT Lags Wall Street’s Rebound Near an 11-Month Low
Previous Story

Microsoft Stock Price Today: Why MSFT Lags Wall Street’s Rebound Near an 11-Month Low

Nokia Stock Price Today: Shares Edge Up After Jefferies Lifts Target as SEB Pulls Back
Next Story

Nokia Stock Price Today: Shares Edge Up After Jefferies Lifts Target as SEB Pulls Back

Go toTop